Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 9—September 2010
CME ACTIVITY - Research

Illicit Drug Use and Risk for USA300 Methicillin-Resistant Staphylococcus aureus Infections with Bacteremia

Kristen M. KreiselComments to Author , J. Kristie Johnson, O. Colin Stine, Michelle D. Shardell, Eli N. Perencevich, Alan J. Lesse, Fred M. Gordin, Michael W. Climo, and Mary-Claire Roghmann
Author affiliations: Author affiliations: University of Maryland, Baltimore, Maryland, USA (K.M. Kreisel, J.K. Johnson, O.C. Stine, M.D. Shardell, E.N. Perencevich, M.-C. Roghmann); VA Maryland Health Care System, Baltimore (K.M. Kreisel, E.N. Perencevich, M.-C. Roghmann); VA Western New York Healthcare System, Buffalo, New York, USA (A.J. Lesse); University at Buffalo, Buffalo (A.J. Lesse); Washington DC VA Medical Center, Washington, DC, USA (F.M. Gordin); George Washington University, Washington (F.M. Gordin); Hunter Holmes McGuire VA Medical Center, Richmond, VA, USA (M.W. Climo); Medical College of Virginia at Virginia Commonwealth University, Richmond (M.W. Climo)

Main Article

Table 3

Patient and infection characteristics for 300 veterans with Staphylococcus aureus bacteremia and association with illicit drug use at 4 Veterans Affairs medical centers, USA, 2004–2008*

Variable
 Used illicit drugs,† n = 22
 No illicit drug use,† n = 278
 p value‡
Patient characteristics
Age, y, mean ± SD 51 ± 5 69 ± 12 <0.0001
Sex
M 20 (7) 275 (93) 0.05
F 2 (40) 3 (60)
Race
Black 16 (17) 79 (83) <0.0001
Other 6 (3) 199 (97)
Year of presentation§
Late 10 (6) 159 (94) 0.29
Early 12 (9) 119 (91)
Charlson score, mean ± SD 5.4 ± 4.1 4.7 ± 2.9 0.28
HIV infection
Yes 6 (38) 10 (62) <0.0001
No 16 (6) 268 (94)
History of colonization or infection with MRSA
Yes 5 (6) 75 (94) 0.66
No 17 (8) 203 (92)
Hospitalized in year before infection
Yes 15 (8) 180 (92) 0.75
No 7 (7) 98 (93)
Surgery in year before infection
Yes 1 (1) 108 (99) <0.0001
No 21 (11) 170 (89)
Residence in LTCF in year before infection
Yes 3 (9) 31 (91) 0.73
No 19 (7) 247 (93)
Renal failure in year before infection
Yes 14 (8) 172 (92) 0.87
No
 8 (7)
 106 (93)
Infection characteristics
Nosocomial infection
Yes 6 (3) 166 (97) 0.003
No 16 (13) 112 (87)
Central line at time of infection
Yes 5 (6) 78 (94) 0.59
No 17 (8) 200 (92)
Permanent hardware at time of infection
Yes 4 (5) 84 (95) 0.33
No 18 (8) 194 (92)
Source of infection
Primary 10 (8) 116 (92) 0.73
Secondary 12 (7) 162 (93)
Infection complicated by endocarditis
Yes 6 (16) 32 (84) 0.04
No 16 (6) 242 (94)
Infection complicated by pneumonia
Yes 3 (7) 42 (93) 1.00
No 19 (7) 236 (93)

*MRSA, methicillin-resistant S. aureus; LTCF, long-term care facility.
†Values are no. (%) except as indicated.
‡Calculated by using Pearson χ2 or Fisher exact tests for categorical variables, Student t test or Wilcoxon signed-rank test for continuous variables.
§Year of presentation stratified into 2 periods: early (January 1, 2004–March 31, 2006) and late (April 1, 2006–June 30, 2008).

Main Article

Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external